BillionToOne

Unverified

Diagnostics labMenlo Park, CAFounded 2016Nasdaq: BLLN

Overview

BillionToOne is a molecular diagnostics company built on a single molecule next-generation sequencing (smNGS) platform that detects and quantifies genetic targets in cell-free DNA. It sells prenatal tests under the UNITY brand (launched 2019) and oncology liquid biopsy tests under the Northstar brand (Northstar Select and Northstar Response). It sells through its own US field sales force.

Hiring snapshot

Open roles

Newest first, from BillionToOne’s careers page.

See all 48 roles →

Divisions

Division information is pending company verification.Once BillionToOne claims its page, you will see each division, who it calls on and how it pays.

Claim your page

More from BillionToOne

These sections fill in when BillionToOne claims and verifies its page.

Life at BillionToOnePhotos, stories and culture. Not added yet.
BenefitsNot added yet.
Is this your company? Claim your page →